|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/00 | |
| C07K 14/72 | |||
| A61K 38/08 | |||
| A61K 38/04 |
| (11) | Patento numeris | 2797615 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12863862.4 |
| Europos patento paraiškos padavimo data | 2012-12-28 | |
| (97) | Europos patento paraiškos paskelbimo data | 2014-11-05 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-04-03 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2012/072026 |
| Data | 2012-12-28 |
| (87) | Numeris | WO 2013/102047 |
| Data | 2013-07-04 |
| (30) | Numeris | Data | Šalis |
| 201161581391 P | 2011-12-29 | US |
| (72) |
TARTAGLIA, Louis, A., US
HENDERSON, Bart, US
|
| (73) |
Rhythm Pharmaceuticals, Inc.,
855 Boylston Street 11th Floor, Boston, MA 02116,
US
|
| (54) | METHOD OF TREATING MELANOCORTIN-4 RECEPTOR-ASSOCIATED DISORDERS IN HETEROZYGOUS CARRIERS |
| METHOD OF TREATING MELANOCORTIN-4 RECEPTOR-ASSOCIATED DISORDERS IN HETEROZYGOUS CARRIERS |